JANESSA SCHOOLFIELD: Open Payments
NPI 1609651090 · FLOYD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 33 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $497 · 2025 $543
Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $239 |
| Novo Nordisk Inc | 7 | $133 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Alkermes, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Bioventus LLC | 1 | $15 |
Products named: VRAYLAR, Ozempic, QULIPTA, Wegovy, AIRSUPRA, VIVITROL, LINZESS, FARXIGA.
Industry payments across VA — which companies pay providers there.
